VIVO - Meridian Bioscience Non-GAAP EPS of $0.16 misses by $0.01 revenue of $67.8M beats by $1M
- Meridian Bioscience press release ( NASDAQ: VIVO ): Q3 Non-GAAP EPS of $0.16 misses by $0.01 .
- Revenue of $67.8M (+6.8% Y/Y) beats by $1M .
- Due to the pending transaction, Meridian will no longer hold conference calls to discuss its quarterly financial results and withdraws its previously issued financial guidance for fiscal year 2022, last updated on May 6, 2022.
For further details see:
Meridian Bioscience Non-GAAP EPS of $0.16 misses by $0.01, revenue of $67.8M beats by $1M